EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aptamer binding footprints discriminate α-synuclein fibrillar polymorphs from different synucleinopathies

Alix Bouvier-Müller, Deborah Fourmy, Alexis Fenyi, Luc Bousset, Ronald Melki, Frédéric Ducongé iD

Nucleic Acids Research · 2024

DOI: 10.1093/nar/gkae544 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Alix Bouvier-Müller und 5 weiteren Autor:innen. Beteiligte Einrichtung: CEA, DRF, Institut of biology JACOB, Molecular Imaging Research Center (MIRCen), Fontenay aux roses 92335, France. Hauptthemen laut MEDLINE: alpha-Synuclein, Aptamers, Nucleotide, Parkinson Disease, Synucleinopathies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale pour la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synucleinopathies, including dementia with Lewy bodies (DLB), Parkinson's disease (PD), and multiple system atrophy (MSA), are characterized by the presence of α-synuclein (α-syn) aggregates in the central nervous system. Recent evidence suggests that the heterogeneity of synucleinopathies may be partly explained by the fact that patients may have different α-syn fibrillar polymorphs with structural differences. In this study, we identify nuclease resistant 2′fluoro-pyrimidine RNA aptamers that can differentially bind to structurally distinct α-syn fibrillar polymorphs. Moreover, we introduce a method, AptaFOOT-Seq, designed to rapidly assess the affinity of a mixture of these aptamers for different α-SYN fibrillar polymorphs using next-generation sequencing. Our findings reveal that the binding behavior of aptamers can be very different when they are tested separately or in the presence of other aptamers. In this case, competition and cooperation can occur, providing a higher level of information, which can be exploited to obtain specific ‘footprints’ for different α-Syn fibrillar polymorphs. Notably, these footprints can distinguish polymorphs obtained from patients with PD, DLB or MSA. This result suggests that aptaFOOT-Seq could be used for the detection of misfolded or abnormal protein conformations to improve the diagnosis of synucleinopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinAptamers, NucleotideParkinson DiseaseSynucleinopathiesHumansMultiple System AtrophyLewy Body DiseaseProtein BindingHigh-Throughput Nucleotide Sequencing

Substanzen

alpha-SynucleinAptamers, NucleotideSNCA protein, human

Autor:innen und Institutionen

  • CEA, DRF, Institut of biology JACOB, Molecular Imaging Research Center (MIRCen), Fontenay aux roses 92335, France.
  • CNRS UMR 9199, Laboratoire des Maladies Neurodégénératives, Fontenay aux roses 92335, France.
  • Université Paris-Saclay, Fontenay aux roses 92335, France.

ORCID-Profile: Frédéric Ducongé

Förderung

  • Agence Nationale pour la Recherche

Zitieren

APA

Bouvier-Müller, A., Fourmy, D., Fenyi, A., Bousset, L., Melki, R., & Ducongé, F. (2024). Aptamer binding footprints discriminate α-synuclein fibrillar polymorphs from different synucleinopathies. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae544

Vancouver

Bouvier-Müller A, Fourmy D, Fenyi A, Bousset L, Melki R, Ducongé F. Aptamer binding footprints discriminate α-synuclein fibrillar polymorphs from different synucleinopathies. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae544

BibTeX
@article{BouvierMller2024,
  author = {Bouvier-Müller, Alix and Fourmy, Deborah and Fenyi, Alexis and Bousset, Luc and Melki, Ronald and Ducongé, Frédéric},
  title = {Aptamer binding footprints discriminate α-synuclein fibrillar polymorphs from different synucleinopathies},
  journal = {Nucleic Acids Research},
  year = {2024},
  doi = {10.1093/nar/gkae544}
}
Kostenlos starten →